Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2021

01-07-2021 | COVID-19 Vaccination | Image of the Month

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding

Authors: Ayah Adel Nawwar, Julie Searle, Rajiv Singh, Iain Douglas Lyburn

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2021

Login to get access

Excerpt

Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed. Many patients with malignancy, a high-risk group, have recently had the first dose of the vaccine. A 75-year-old male with prostate cancer and biochemical recurrence underwent [18F]Choline PET/CT for disease assessment. No choline avid malignancy was identified; however, avid left axillary nodes were noted. …
Literature
1.
Calabria F, Chiaravalloti A, Schillaci O. 18F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. Clin Nucl Med. 2014;39:122–30.CrossRef
2.
Eifer M, Eshet Y. Imaging of COVID-19 vaccination at FDG PET/CT. Radiology. 2021;210030.
Metadata
Title
Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding
Authors
Ayah Adel Nawwar
Julie Searle
Rajiv Singh
Iain Douglas Lyburn
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2021
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-021-05279-2

Other articles of this Issue 8/2021

European Journal of Nuclear Medicine and Molecular Imaging 8/2021 Go to the issue

Original Article

A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals

Original Article

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma

Original Article

Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma

Image of the Month

Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the “flare phenomenon” to the “abscopal effect”

Original Article

Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT

Original Article

A deep learning framework for 18F-FDG PET imaging diagnosis in pediatric patients with temporal lobe epilepsy